Clinical trials
Terminated Breast Neoplasms trials in Switzerland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Swiss Cancer Institute | 5 |
| ETOP IBCSG Partners Foundation | 2 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Cellestia Biotech AG | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Eli Lilly and Company | 1 |
| Insel Gruppe AG, University Hospital Bern | 1 |
| Ipsen | 1 |
| Jules Bordet Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 19 |
| Adenocarcinoma | 1 |
| Alzheimer Disease | 1 |
| Breast Diseases | 1 |
| Carcinoma, Adenoid Cystic | 1 |
| Carcinoma, Hepatocellular | 1 |
| Cardiotoxicity | 1 |
| Colorectal Neoplasms | 1 |
| Glomus Tumor | 1 |
| Heart Failure | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.